The Epilepsy Pathway Innovations in Africa (EPInA) team recently convened a two-day dissemination meeting in Nairobi, bringing together key stakeholders to accelerate the implementation of the World Health Organization’s Intersectoral Global Action Plan (IGAP) on epilepsy and neurological health. Implemented across Kilifi and Nairobi in Kenya, as well as in Ghana and Tanzania, the EPInA […]

As the world marked International Women’s Day under the theme “Rights. Justice. Action. For ALL Women and Girls,” we spotlight the inspiring journey of Dorcas Kamuya, Head of the Health Systems and Research Ethics Department at the KEMRI-Wellcome Trust Research Programme. Her work sits at the intersection of science, ethics, and community ensuring that research […]

The AMR Kenya 2026 Conference, held on 21–22 January 2026 at Serena Beach Resort & Spa in Mombasa, brought together experts, policymakers, funders, researchers, and community leaders to co-create practical, locally relevant solutions to antimicrobial resistance (AMR) in Kenya and across the region. Convened under the theme “Working Together to Tackle AMR in Kenya,” the […]

The Novo Nordisk Foundation paid a courtesy visit to the Programme in Kilifi, engaging with researchers and leadership to learn more about its work and impact. The visit included tours of the Programme’s research laboratories, presentations on its cutting-edge research and capacity-building initiatives, and a visit to the hypertension research clinic. Discussions highlighted the Programme’s […]

KEMRI-Wellcome participated in the 3rd Kilifi County Health Scientific Symposium, held under the theme “Sustaining Universal Health Coverage: Innovations, Research, and Best Practices.” The symposium brought together policymakers, researchers, healthcare professionals, and partners to reflect on evidence-based solutions for strengthening health systems and improving health outcomes in Kilifi County and beyond. Organized by the Kilifi […]

An international study has identified a blood-based indicator of intestinal damage and inflammation that strongly predicts mortality in sick children. The new biomarker could help to identify those children at greatest risk of dying after hospitalisation in parts of the world with limited resources. The collaborative study by the University of Oxford and the international […]

A new international consortium has been established to advance the development of a next-generation malaria vaccine that aims to extend the protection against malaria and help lead to future efforts to eliminate it by targeting multiple stages of the parasite’s life-cycle. The 2nd Generation Malaria Vaccine Consortium (MVC-2G) will be co-led by Professor Angela Minassian […]

Newborn infections remain one of the leading causes of infant deaths globally, and antimicrobial resistance is worsening the situation. In Kenya and across Africa, neonatal sepsis continues to claim thousands of lives each year, often due to bacteria that no longer respond to standard treatments. As part of World AMR Awareness Week (WAAW) 2025, we […]

The Programme hosted its annual Media Advisory Group (MAG) meeting on November 6-7, 2025, under the theme Reflect and Engage: Strengthening Media-Researcher Collaboration. 13 MAG members attended the two-day meeting. Founded in 2021, MAG brings together journalists, editors, social media experts, and community representatives to advise on research dissemination and foster meaningful collaboration between the […]

The Accelerating CHikungunya burden Estimation to inform Vaccine Evaluation (ACHIEVE) study has officially launched! The #ACHIEVE study is a 3-year multi-country, multi-site research project led by the University of Oxford in collaboration with the KEMRI-Wellcome Trust Research Programme, KEMRI-Centre for Global Health Research, the University of Nairobi – Centre for Epidemiological Modelling and Analysis (UON-CEMA), and […]